Compare BioNano Genomics Inc (BNGO) vs Etsy Inc (ETSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Etsy Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Etsy Inc trades at $85.5 (market cap $7.88B). The key difference: Etsy Inc is far larger — about 597× BioNano Genomics Inc's market cap, and Etsy Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | ETSY | |
|---|---|---|
Market Cap | $13.20M | $7.88B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $83.06 |
52-Week Low | $1.09 | $44.05 |
Enterprise Value | $15.81M | $9.53B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
ETSY trades at $80.53, down 0.64% today, with strong technical momentum as the stock has rallied 40% over the past three months. The company shows mixed fundamentals with revenue stabilizing around $2.9B but net income declining to $163M in 2025. Recent earnings beats and positive analyst sentiment (48.9% buy ratings) support the bullish technical outlook, though valuation metrics remain elevated with a P/E of 30.85.
The outlook remains cautiously optimistic with AI-driven marketplace improvements and seller tools driving growth potential. Key risks include active buyer declines, competitive pressures from larger e-commerce players, and high debt levels. The stock trades near analyst consensus targets, suggesting limited near-term upside from current levels despite positive momentum indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
